Actively Recruiting
Comparing Radiation Therapy with Cetuximab Versus Chemotherapy Using Carboplatin and Paclitaxel for Advanced Head and Neck Cancer in Patients Unsuitable for Cisplatin
Led by NRG Oncology · Updated on 2026-10-27
454
Participants Needed
150
Research Sites
261 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating treatments for patients with advanced head and neck cancer that has spread locally or to distant parts and who cannot receive cisplatin. This phase III trial compares two approaches combined with intensity modulated radiation therapy IMRT cetuximab, a monoclonal antibody targeting EGFR on cancer cells, versus chemotherapy with carboplatin and paclitaxel. The study aims to determine which treatment better controls the cancer and improves survival while considering safety and quality of life. Participants are randomly assigned to one of two groups. One group receives IMRT five days per week for 35 treatments alongside cetuximab given intravenously as a loading dose before radiation and then weekly concurrent infusions for seven cycles. The other group receives the same IMRT schedule with weekly intravenous carboplatin and paclitaxel for seven cycles during radiation. Both groups undergo imaging scans like CT, MRI, or PETCT during screening and follow-up, as well as blood sample collections throughout the study. Participants are followed after treatment completion at 30 days, then at 4, 6, 12, 18, 24, 30, and 36 months, and annually thereafter. Researchers collect data on cancer progression, survival, treatment side effects, and changes in diet, eating, and speech. The main outcome measured is progression-free survival up to eight years, with additional monitoring of overall survival, adverse events, patterns of cancer recurrence, and quality of life changes over time.
CONDITIONS
Brief Title
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here